-
2 months ago | 
healthday.com | Tina DiMarcantonio Brown
Published on: Apr 01, 2025, 8:53 pmUpdated on: Apr 01, 2025, 8:53 pmLoading content, please wait...
-
Jan 22, 2025 | 
healthday.com | Tina DiMarcantonio Brown
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- In one of his first presidential actions on Monday, President Trump issued an executive order withdrawing the United States from the World Health Organization. The executive order retracts a Presidential Letter by President Biden on Jan. 20, 2021, revoking the original withdrawal by Trump in his last term on July 6, 2020.
-
Oct 1, 2024 | 
healthday.com | Tina DiMarcantonio Brown
Hi, I'm Cristina Granziera. I'm part of a member of the Executive Committee of ECTRIMS. I'm also a neurologist, clinically active at the University Hospital Basel, and I'm co-directing the Research Center for Clinical Neuroimmunology and Neuroscience in Basel. So ECTRIMS this year was a special ECTRIMS because it was the 40th anniversary of the conference.
-
Sep 27, 2024 | 
healthday.com | Tina DiMarcantonio Brown
The annual Congress of the European Committee for Treatment and Research in Multiple Sclerosis was held from Sept. 18 to 20 in Copenhagen, Denmark, and drew more than 8,500 delegates from around the world, including clinicians and researchers in multiple sclerosis (MS).
-
May 23, 2024 | 
healthday.com | Tina DiMarcantonio Brown
THURSDAY, May 23, 2024 (HealthDay News) -- The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held May 31 to June 4, 2024, in Chicago and online. The theme of this year's meeting is The Art and Science of Cancer Care: From Comfort to Cure. Attendees will share and discuss the latest clinical cancer research impacting patient care.
-
Mar 18, 2024 | 
healthday.com | Tina DiMarcantonio Brown |Mark Arredondo
MONDAY, March 18, 2024 (HealthDay News) -- Lebrikizumab demonstrates improvement in skin clearance and itch relief in patients with skin of color and moderate-to-severe atopic dermatitis, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 12 in San Diego.
-
Mar 18, 2024 | 
healthday.com | Tina DiMarcantonio Brown |Mark Arredondo
MONDAY, March 18, 2024 (HealthDay News) -- Continuous treatment with baricitinib in patients with severe alopecia areata demonstrates improvement in hair regrowth outcomes through 76 weeks of follow-up, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 12 in San Diego. Rodney D.
-
Mar 15, 2024 | 
healthday.com | Tina DiMarcantonio Brown |Mark Arredondo
FRIDAY, March 15, 2024 (HealthDay News) -- Short-term exposure to wildfire-related air pollution is associated with an increase in clinic visits for acne vulgaris among adults, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 10 in San Diego. Alex Ha, from the University of California, San Francisco, and colleagues conducted a retrospective cohort study to determine environmental triggers and factors for acne vulgaris.
-
Mar 15, 2024 | 
healthday.com | Tina DiMarcantonio Brown |Mark Arredondo
FRIDAY, March 15, 2024 (HealthDay News) -- Patients with psoriasis treated with bimekizumab rapidly achieve high levels of clinical and health-related quality-of-life responses that are durable at four years, according to research presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 10 in San Diego.
-
Sep 11, 2023 | 
consumer.healthday.com | Tina DiMarcantonio Brown
×Fact CheckedHealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy. All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
